| ƒJƒ^ƒƒO”Ô† | •iŽíƒR[ƒh | •i–¼ | “à—e—Ê | Å”²•W€‰¿Ši(‰~) |
| 01-027-412 | P0001-01 | HeLa Cell Nuclear Extract (for in vitro transcription) | 200 ul | 55,000 |
| 01-027-413 | P0001-02 | HeLa Cell Nuclear Extract (for in vitro transcription) | 500 ul | 110,000 |
| 01-027-411 | P0002-01 | HeLa Cell Nuclear Extract (for in vitro pre-mRNA splicing) | 200 ul | 55,000 |
| 01-027-410 | P0002-02 | HeLa Cell Nuclear Extract (for in vitro pre-mRNA splicing) | 500 ul | 110,000 |
| 01-027-305 | P0003-01 | 293 Cell Nuclear Extract (for in vitro pre-mRNA splicing) | 200 ul | 55,000 |
| 01-027-306 | P0003-02 | 294 Cell Nuclear Extract (for in vitro pre-mRNA splicing) | 500 ul | 110,000 |
| 01-027-541 | P0004-01 | HeLa Cell Cytosol Extract (S100) | 200 ul | 55,000 |
| 01-027-542 | P0004-02 | HeLa Cell Cytosol Extract (S100) | 500 ul | 110,000 |
| 01-027-334 | P1041-01 | BRG1 (Brahma-related Gene 1 Protein, wild type) | 5,000 units (ng) | 112,000 |
| 01-027-333 | P1041-02 | BRG1 (Brahma-related Gene 2 Protein, wild type) | 12,500 units (ng) | 223,000 |
| 01-027-335 | P1042-01 | BRG1-mt (Brahma-related Gene 1 Protein, K798R) | 5,000 units (ng) | 93,000 |
| 01-027-336 | P1042-02 | BRG1-mt (Brahma-related Gene 1 Protein, K798R) | 12,500 units (ng) | 185,000 |
| 01-027-337 | P1035-01 | CTF1 CCAAT-Box-Binding Transcription Factor 1 (Recombinant Protein from Insect Cells) | 5,000 units (ng) | 112,000 |
| 01-027-338 | P1035-02 | CTF1 CCAAT-Box-Binding Transcription Factor 1 (Recombinant Protein from Insect Cells) | 12,500 units (ng) | 223,000 |
| 01-027-339 | P1024-01 | Dr1 (NC2b 19 kDa) | 10,000 units (ng) | 70,000 |
| 01-027-340 | P1024-02 | Dr1 (NC2b 19 kDa) | 25,000 units (ng) | 140,000 |
| 01-027-341 | P1031-01 | E2F-1, (RBAP-1) Transcription Factor and Rb-mediator | 5,000 units (ng) | 112,000 |
| 01-027-342 | P1031-02 | E2F-1, (RBAP-1) Transcription Factor and Rb-mediator | 12,500 units (ng) | 223,000 |
| 01-027-345 | P1018-01 | GAL4-AH [GAL4(1-147) + AH] | 10,000 units (ng) | 74,000 |
| 01-027-346 | P1018-02 | GAL4-AH [GAL4(1-147) + AH] | 25,000 units (ng) | 148,000 |
| 01-027-351 | P1019-01 | GAL4-VP16 [GAL4(1-147) + VP16(411-490)] | 10,000 units (ng) | 74,000 |
| 01-027-352 | P1019-02 | GAL4-VP16 [GAL4(1-147) + VP16(411-490)] | 25,000 units (ng) | 148,000 |
| 01-027-347 | P1020-01 | GAL4-E1A [GAL4(1-147) + E1A(121-223)] | 4,000 units (ng) | 93,000 |
| 01-027-348 | P1020-02 | GAL4-E1A [GAL4(1-147) + E1A(121-223)] | 10,000 units (ng) | 185,000 |
| 01-027-414 | P1025-01 | HMG1 (High Mobility Group 1 protein) Low Endotoxin, <0.25 EU/ml | 10,000 units (ng) | 74,000 |
| 01-027-415 | P1025-02 | HMG1 (High Mobility Group 1 protein) Low Endotoxin, <0.25 EU/ml | 25,000 units (ng) | 148,000 |
| 01-027-521 | P1058-01 | HMG1 (Native from Calf Thymus) | 10,000 units(ng) | 93,000 |
| 01-027-522 | P1058-02 | HMG1 (Native from Calf Thymus) | 25,000 units(ng) | 185,000 |
| 01-027-451 | P1014-01 | RNA pol II (RNA polymerase II, native complex) | 2,000 units (ng) | 149,000 |
| 01-027-450 | P1014-02 | RNA pol II (RNA polymerase II, native complex) | 5,000 units (ng) | 298,000 |
| 01-027-452 | P1015-01 | RNA pol II-CTD (RNA polymerase II, carboxy-terminal domain) | 10,000 units (ng) | 74,000 |
| 01-027-453 | P1015-02 | RNA pol II-CTD (RNA polymerase II, carboxy-terminal domain) | 25,000 units (ng) | 148,000 |
| 01-027-454 | P1016-01 | RNA pol II-hRPB5 (RNA polymerase II, p33 subunit) | 10,000 units (ng) | 74,000 |
| 01-027-455 | P1016-02 | RNA pol II-hRPB5 (RNA polymerase II, p33 subunit) | 25,000 units (ng) | 148,000 |
| 01-027-456 | P1017-01 | RNA pol II-hRPB9 (RNA polymerase II, p14.5 subunit) | 10,000 units (ng) | 74,000 |
| 01-027-457 | P1017-02 | RNA pol II-hRPB9 (RNA polymerase II, p14.5 subunit) | 25,000 units (ng) | 148,000 |
| 01-027-466 | P1033-01 | Sp1 GC-box Binding Protein (Natural fraction purified from HeLa Cells) | 2,000 units (ng) | 117,000 |
| 01-027-467 | P1033-02 | Sp1 GC-box Binding Protein (Natural fraction purified from HeLa Cells) | 5,000 units (ng) | 233,000 |
| 01-027-468 | P1034-01 | Sp1 GC-box Binding Protein (Recombinant protein purified from insect cells) | 5,000 units (ng) | 112,000 |
| 01-027-469 | P1034-02 | Sp1 GC-box Binding Protein (Recombinant protein purified from insect cells) | 12,500 units (ng) | 223,000 |
| 01-027-689 | R1072-01 | STAT1 (Signal transducer and activator of transcription 1) | 10,000 units (ng) | 117,000 |
| 01-027-690 | R1072-02 | STAT1 (Signal transducer and activator of transcription 1) | 25,000 units (ng) | 233,000 |
| 01-027-543 | P1071-01 | STAT3 (Signal transducer and activator of transcription 3) | 10,000 units (ng) | 74,000 |
| 01-027-544 | P1071-02 | STAT3 (Signal transducer and activator of transcription 3) | 25,000 units (ng) | 148,000 |
| 01-027-545 | P1073-01 | STAT4 (Signal transducer and activator of transcription 4) | ¦ | 74,000 |
| 01-027-546 | P1073-02 | STAT4 (Signal transducer and activator of transcription 4) | ¦ | 148,000 |
| 01-027-470 | P1004-01 | TBP (TATA box Binding Protein) | 10,000 units (ng) | 74,000 |
| 01-027-471 | P1004-02 | TBP (TATA box Binding Protein) | 25,000 units (ng) | 148,000 |
| 01-027-472 | P1032-01 | TFIIA (Transcription Factor IIA, reconstituted) | 10,000 units (ng) | 74,000 |
| 01-027-473 | P1032-02 | TFIIA (Transcription Factor IIA, reconstituted) | 25,000 units (ng) | 148,000 |
| 01-027-476 | P1001-01 | TFIIA-p55 (Transcription Factor IIA, p55 subunit) | 10,000 units (ng) | 74,000 |
| 01-027-477 | P1001-02 | TFIIA-p55 (Transcription Factor IIA, p55 subunit) | 25,000 units (ng) | 148,000 |
| 01-027-474 | P1002-01 | TFIIA-p12 (Transcription Factor IIA, subunit) | 10,000 units (ng) | 74,000 |
| 01-027-475 | P1002-02 | TFIIA-p12 (Transcription Factor IIA, subunit) | 25,000 units (ng) | 148,000 |
| 01-027-478 | P1003-01 | TFIIB (Transcription Factor IIB) | 10,000 units (ng) | 74,000 |
| 01-027-479 | P1003-02 | TFIIB (Transcription Factor IIB) | 25,000 units (ng) | 148,000 |
| 01-027-480 | P1013-01 | TFIID (Transcription Factor IID, native complex) | 2,000 units (ng) | 131,000 |
| 01-027-481 | P1013-02 | TFIID (Transcription Factor IID, native complex) | 5,000 units (ng) | 261,000 |
| 01-027-484 | P1005-01 | TFIIEa, p56 (Transcription Factor IIE, a subunit) | 10,000 units (ng) | 74,000 |
| 01-027-485 | P1005-02 | TFIIEa, p56 (Transcription Factor IIE, a subunit) | 25,000 units (ng) | 148,000 |
| 01-027-486 | P1006-01 | TFIIEb, p34 (Transcription Factor IIE, b subunit) | 10,000 units (ng) | 74,000 |
| 01-027-487 | P1006-02 | TFIIEb, p34 (Transcription Factor IIE, b subunit) | 25,000 units (ng) | 148,000 |
| 01-027-482 | P1007-01 | TFIIE (Transcription Factor IIE, a+b subunits) | 10,000 units (ng) | 74,000 |
| 01-027-483 | P1007-02 | TFIIE (Transcription Factor IIE, a+b subunits) | 25,000 units (ng) | 148,000 |
| 01-027-492 | P1008-01 | TFIIF, RAP74 (Transcription Factor IIF, Rap74 subunit) | 10,000 units (ng) | 74,000 |
| 01-027-493 | P1008-02 | TFIIF, RAP74 (Transcription Factor IIF, Rap74 subunit) | 25,000 units (ng) | 148,000 |
| 01-027-490 | P1009-01 | TFIIF, RAP30 (Transcription Factor IIF, Rap30 subunit) | 10,000 units (ng) | 74,000 |
| 01-027-491 | P1009-02 | TFIIF, RAP30 (Transcription Factor IIF, Rap30 subunit) | 25,000 units (ng) | 148,000 |
| 01-027-488 | P1010-01 | TFIIF (Transcription Factor IIF, RAP30+Rap74) | 10,000 units (ng) | 74,000 |
| 01-027-489 | P1010-02 | TFIIF (Transcription Factor IIF, RAP30+Rap74) | 25,000 units (ng) | 148,000 |
| 01-027-495 | P1011-01 | TFIIH (Transcription Factor IIH, native complex) | 2,000 units (ng) | 149,000 |
| 01-027-494 | P1011-02 | TFIIH (Transcription Factor IIH, native complex) | 5,000 units (ng) | 298,000 |
| 01-027-496 | P1012-01 | TFIIH-p62 (Transcription Factor IIH, p62 subunit) | 10,000 units (ng) | 74,000 |
| 01-027-497 | P1012-02 | TFIIH-p62 (Transcription Factor IIH, p62 subunit) | 25,000 units (ng) | 148,000 |
| 01-027-508 | P1036-01 | Topo I - Human DNA Topoisomerase I (wild type) | 5,000 units (ng) | 93,000 |
| 01-027-498 | P1036-02 | Topo I - Human DNA Topoisomerase I (wild type) | 12,500 units (ng) | 185,000 |
| 01-027-502 | P1037-01 | Topo I (C651-765) Human DNA Topoisomerase I (C terminal domain) | 5,000 units (ng) | 93,000 |
| 01-027-503 | P1037-02 | Topo I (C651-765) Human DNA Topoisomerase I (C terminal domain) | 12,500 units (ng) | 185,000 |
| 01-027-499 | P1038-01 | Topo I (197-651) Human DNA Topoisomerase I (Core Domain) | 5,000 units (ng) | 93,000 |
| 01-027-501 | P1038-02 | Topo I (197-651) Human DNA Topoisomerase I (Core Domain) | 12,500 units (ng) | 185,000 |
| 01-027-504 | P1039-01 | Topo I (N1-197) Human DNA Topoisomerase I (NTD) | 5,000 units (ng) | 93,000 |
| 01-027-505 | P1039-02 | Topo I (N1-197) Human DNA Topoisomerase I (NTD) | 12,500 units (ng) | 185,000 |
| 01-027-507 | P1040-01 | Topo I (Y723F) Human DNA Topoisomerase I (mt Y723F) | 5,000 units (ng) | 93,000 |
| 01-027-506 | P1040-02 | Topo I (Y723F) Human DNA Topoisomerase I (mt Y723F) | 12,500 units (ng) | 185,000 |
| 01-027-547 | P1062-01 | USF1 (Human Upstream Stimulatory Factor 1) | 10,000 units (ng) | 85,000 |
| 01-027-548 | P1062-02 | USF1 (Human Upstream Stimulatory Factor 1) | 25,000 units (ng) | 170,000 |
| 01-027-691 | R1089-01 | AR (Androgen Receptor) | 5,000 units (ng) | 117,000 |
| 01-027-692 | R1089-02 | AR (Androgen Receptor) | 12,500 units (ng) | 233,000 |
| 01-027-549 | P1090-01 | AR-LBD [650-920] (Androgen Receptor, Ligand Binding Domain) | 10,000 units (ng) | 93,000 |
| 01-027-550 | P1090-02 | AR-LBD [650-920] (Androgen Receptor, Ligand Binding Domain) | 25,000 units (ng) | 185,000 |
| 01-027-551 | P1085-01 | CAR-LBD [101-348] (Constitutive Androstane Receptor, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-552 | P1085-02 | CAR-LBD [101-348] (Constitutive Androstane Receptor, ligand binding domain) | 25,000 units (ng) | 170,000 |
| 01-027-553 | P1057-01 | ER (Estrogen Receptor) | 4,000 units(ng) | 117,000 |
| 01-027-554 | P1057-02 | ER (Estrogen Receptor) | 10,000 units(ng) | 233,000 |
| 01-027-343 | P1044-01 | FXR (Farnesoid-X-activated Receptor) | 10,000 units (ng) | 74,000 |
| 01-027-344 | P1044-02 | FXR (Farnesoid-X-activated Receptor) | 25,000 units (ng) | 146,000 |
| 01-027-555 | P1067-01 | FXR-LBD [222-472] (Farnesoid-X-activated Receptor, ligand binding domain) | 10,000 units (ng) | 74,000 |
| 01-027-556 | P1067-02 | FXR-LBD [222-472] (Farnesoid-X-activated Receptor, ligand binding domain) | 25,000 units (ng) | 146,000 |
| 01-027-353 | P1051-01 | GR (Glucocorticoid Receptor) | 5,000 units (ng) | 93,000 |
| 01-027-354 | P1051-02 | GR (Glucocorticoid Receptor) | 12,500 units (ng) | 185,000 |
| 01-027-557 | P1088-01 | LRH-1 (Liver Receptor Homologue-1, nuclear receptor subfamily 5, group A, member 2 isoform 1) | 5,000 units (ng) | 93,000 |
| 01-027-558 | P1088-02 | LRH-1 (Liver Receptor Homologue-1, nuclear receptor subfamily 5, group A, member 2 isoform 1) | 12,500 units (ng) | 185,000 |
| 01-027-418 | P1045-01 | LXR-a (Liver-X Receptor, alpha isoform) | 10,000 units (ng) | 74,000 |
| 01-027-419 | P1045-02 | LXR-a (Liver-X Receptor, alpha isoform) | 25,000 units (ng) | 146,000 |
| 01-027-416 | P1047-01 | LXRƒ¿-LBD [215-667] (Liver-X Receptor, alpha, ligand binding domain) | 10,000 units (ng) | 70,000 |
| 01-027-417 | P1047-02 | LXRƒ¿-LBD [215-667] (Liver-X Receptor, alpha, ligand binding domain) | 25,000 units (ng) | 140,000 |
| 01-027-420 | P1046-01 | LXR-b (Liver-X Receptor, beta isoform) | 10,000 units (ng) | 74,000 |
| 01-027-421 | P1046-02 | LXR-b (Liver-X Receptor, beta isoform) | 25,000 units (ng) | 146,000 |
| 01-027-559 | P1066-01 | LXRb-LBD [211-461] (Liver-X Receptor, beta isoform, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-560 | P1066-02 | LXRb-LBD [211-461] (Liver-X Receptor, beta isoform, ligand binding domain) | 25,000 units (ng) | 169,000 |
| 01-027-442 | P1048-01 | PPAR-a (Peroxisome proliferator-activated receptor, alpha isotype) | 10,000 units (ng) | 74,000 |
| 01-027-443 | P1048-02 | PPAR-a (Peroxisome proliferator-activated receptor, alpha isotype) | 25,000 units (ng) | 146,000 |
| 01-027-561 | P1063-01 | PPARa-LBD [170-468] (Peroxisome proliferator-activated receptor, alpha, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-562 | P1063-02 | PPARa-LBD [170-468] (Peroxisome proliferator-activated receptor, alpha, ligand binding domain) | 25,000 units (ng) | 169,000 |
| 01-027-444 | P1049-01 | PPAR-b (Peroxisome proliferator-activated receptor, beta isotype) | 10,000 units (ng) | 74,000 |
| 01-027-445 | P1049-02 | PPAR-b (Peroxisome proliferator-activated receptor, beta isotype) | 25,000 units (ng) | 146,000 |
| 01-027-563 | P1064-01 | PPARb-LBD [165-441] (Peroxisome proliferator-activated receptor, beta, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-564 | P1064-02 | PPARb-LBD [165-441] (Peroxisome proliferator-activated receptor, beta, ligand binding domain) | 25,000 units (ng) | 169,000 |
| 01-027-446 | P1050-01 | PPAR-g (Peroxisome proliferator-activated receptor, gamma isotype) | 10,000 units (ng) | 74,000 |
| 01-027-447 | P1050-02 | PPAR-g (Peroxisome proliferator-activated receptor, gamma isotype) | 25,000 units (ng) | 146,000 |
| 01-027-565 | P1065-01 | PPARg-LBD [204-477] (Peroxisome proliferator-activated receptor, gamma, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-566 | P1065-02 | PPARg-LBD [204-477] (Peroxisome proliferator-activated receptor, gamma, ligand binding domain) | 25,000 units (ng) | 169,000 |
| 01-027-693 | R1082-01 | PXR (Pregnane X Receptor) | 5,000 units (ng) | 85,000 |
| 01-027-694 | R1082-02 | PXR (Pregnane X Receptor) | 12,500 units (ng) | 170,000 |
| 01-027-567 | P1054-01 | RAR-a (Retinoic Acid Receptor, alpha isoform) | 5,000 units(ng) | 97,000 |
| 01-027-568 | P1054-02 | RAR-a (Retinoic Acid Receptor, alpha isoform) | 12,500 units(ng) | 194,000 |
| 01-027-569 | P1068-01 | RARa-LBD [154-462] (Retinoic Acid Receptor, alpha, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-570 | P1068-02 | RARa-LBD [154-462] (Retinoic Acid Receptor, alpha, ligand binding domain) | 25,000 units (ng) | 169,000 |
| 01-027-571 | P1056-01 | RAR-b (Retinoic Acid Receptor, beta isoform) | 5,000 units(ng) | 97,000 |
| 01-027-572 | P1056-02 | RAR-b (Retinoic Acid Receptor, beta isoform) | 12,500 units(ng) | 194,000 |
| 01-027-573 | P1055-01 | RAR-g (Retinoic Acid Receptor, gamma isoform) | 5,000 units(ng) | 93,000 |
| 01-027-574 | P1055-02 | RAR-g (Retinoic Acid Receptor, gamma isoform) | 12,500 units(ng) | 194,000 |
| 01-027-575 | P1070-01 | RARg-LBD [150-417] (Retinoic Acid Receptor, gamma, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-576 | P1070-02 | RARg-LBD [150-417] (Retinoic Acid Receptor, gamma, ligand binding domain) | 25,000 units (ng) | 169,000 |
| 01-027-458 | P1022-01 | RXR-a (Retinoid X receptor alpha) | 10,000 units (ng) | 74,000 |
| 01-027-459 | P1022-02 | RXR-a (Retinoid X receptor alpha) | 25,000 units (ng) | 148,000 |
| 01-027-460 | P1043-01 | RXRa-LBD [200-462] (Retinoid X Receptor-alpha, ligand binding domain) | 10,000 units (ng) | 70,000 |
| 01-027-461 | P1043-02 | RXRa-LBD [200-462] (Retinoid X Receptor-alpha, ligand binding domain) | 25,000 units (ng) | 140,000 |
| 01-027-462 | P1053-01 | RXR-b (Retinoid X Receptor, beta isoform) | 5000 units (ng) | 85,000 |
| 01-027-463 | P1053-02 | RXR-b (Retinoid X Receptor, beta isoform) | 12500 units (ng) | 170,000 |
| 01-027-695 | R1083-01 | Rev-ErbA-beta (RVR) | 5,000 units (ng) | 85,000 |
| 01-027-696 | R1083-02 | Rev-ErbA-beta (RVR) | 12,500 units (ng) | 170,000 |
| 01-027-509 | P1052-01 | TR-a1 (Thyroid Hormone Receptor, a1 isoform) | 5000 units (ng) | 85,000 |
| 01-027-510 | P1052-02 | TR-a1 (Thyroid Hormone Receptor, a1 isoform) | 12500 units (ng) | 170,000 |
| 01-027-511 | P1023-01 | TR-b1 (Thyroid Hormone Receptor, b1 isoform) | 10,000 units (ng) | 74,000 |
| 01-027-512 | P1023-02 | TR-b1 (Thyroid Hormone Receptor, b1 isoform) | 25,000 units (ng) | 148,000 |
| 01-027-697 | R1084-01 | VDR (Vitamin D Receptor) | 5,000 units (ng) | 93,000 |
| 01-027-698 | R1084-02 | VDR (Vitamin D Receptor) | 12,500 units (ng) | 185,000 |
| 01-027-599 | P1069-01 | RARb-LBD [173-409] (Retinoic Acid Receptor, beta, ligand binding domain) | 10,000 units (ng) | 85,000 |
| 01-027-600 | P1069-02 | RARb-LBD [173-409] (Retinoic Acid Receptor, beta, ligand binding domain) | 25,000 units (ng) | 169,000 |
| 01-027-526 | P1091-01 | HDAC3 (Histone Deacetylase) | 5,000 units (ng) | 93,000 |
| 01-027-527 | P1091-02 | HDAC3 (Histone Deacetylase) | 12,500 units (ng) | 185,000 |
| 01-027-528 | P1092-01 | N-CoR (Nuclear Receptor Co-Repressor 1) | 5,000 units (ng) | 112,000 |
| 01-027-529 | P1092-02 | N-CoR (Nuclear Receptor Co-Repressor 1) | 10,000 units (ng) | 223,000 |
| 01-027-699 | R2023-01 | PCAF (p300/CBP-associated factor) | 5,000 units (ng) | 93,000 |
| 01-027-700 | R2023-02 | PCAF (p300/CBP-associated factor) | 12,500 units (ng) | 185,000 |
| 01-027-436 | P1026-01 | PC4 (Positive Cofactor 4, wild type) Transcriptional Coactivator | 10,000 units (ng) | 74,000 |
| 01-027-437 | P1026-02 | PC4 (Positive Cofactor 4, wild type) Transcriptional Coactivator | 25,000 units (ng) | 148,000 |
| 01-027-438 | P1027-01 | PC4-mt (Positive Cofactor 4, F77P mutant) Transcriptional Coactivator | 10,000 units (ng) | 74,000 |
| 01-027-439 | P1027-02 | PC4-mt (Positive Cofactor 4, F77P mutant) Transcriptional Coactivator | 25,000 units (ng) | 148,000 |
| 01-027-440 | P1028-01 | PC4-mt (Positive Cofactor 4, serine mutations) Transcriptional Coactivator | 10,000 units (ng) | 74,000 |
| 01-027-441 | P1028-02 | PC4-mt (Positive Cofactor 4, serine mutations) Transcriptional Coactivator | 25,000 units (ng) | 148,000 |
| 01-027-426 | P1029-01 | p52, Transcriptional Coactivator | 10,000 units (ng) | 93,000 |
| 01-027-427 | P1029-02 | p52, Transcriptional Coactivator | 25,000 units (ng) | 185,000 |
| 01-027-434 | P1030-01 | p75, Transcriptional Coactivator and Lens Epithelial Cell-Derived Growth Factor | 10,000 units (ng) | 93,000 |
| 01-027-435 | P1030-02 | p75, Transcriptional Coactivator and Lens Epithelial Cell-Derived Growth Factor | 25,000 units (ng) | 185,000 |
| 01-027-577 | P1061-01 | p75-CTR [C-terminal region of p75 (LEDGF)] | 10,000 units (ng) | 93,000 |
| 01-027-578 | P1061-02 | p75-CTR [C-terminal region of p75 (LEDGF)] | 25,000 units (ng) | 185,000 |
| 01-027-422 | P2004-01 | p300 (Tumor Suppressor Protein and Transcription Factor) | 4,000 units (ng) | 112,000 |
| 01-027-425 | P2004-02 | p300 (Tumor Suppressor Protein and Transcription Factor) | 10,000 units (ng) | 223,000 |
| 01-027-579 | P2022-01 | p300-Ch1 [302-531] | 10,000 units (ng) | 85,000 |
| 01-027-580 | P2022-02 | p300-Ch1 [302-531] | 25,000 units (ng) | 170,000 |
| 01-027-423 | P2012-01 | p300 [C1135-2414] (Tumor Suppressor Protein and Transcription Factor) C-terminus | 4,000 units (ng) | 112,000 |
| 01-027-424 | P2012-02 | p300 [C1135-2414] (Tumor Suppressor Protein and Transcription Factor) C-terminus | 10,000 units (ng) | 223,000 |
| 01-027-581 | P1087-01 | SRC1-RID Non-tagged (Steroid Receptor Coactivator1-receptor interaction domain, non-tagged) | 10,000 units (ng) | 112,000 |
| 01-027-582 | P1087-02 | SRC1-RID Non-tagged (Steroid Receptor Coactivator1-receptor interaction domain, non-tagged) | 25,000 units (ng) | 223,000 |
| 01-027-583 | P1080-01 | SRC1-RID [627-786] (Steroid Receptor Coactivator 1-receptor interaction domain) | 10,000 units (ng) | 74,000 |
| 01-027-584 | P1080-02 | SRC1-RID [627-786] (Steroid Receptor Coactivator 1-receptor interaction domain) | 25,000 units (ng) | 148,000 |
| 01-027-585 | P1079-01 | SRC1-RID [627-786] Biotinylated / His Tagged (Steroid Receptor Coactivator1-receptor interaction domain) | 5,000 units (ng) | 67,000 |
| 01-027-586 | P1079-02 | SRC1-RID [627-786] Biotinylated / His Tagged (Steroid Receptor Coactivator1-receptor interaction domain) | 12,500 units (ng) | 133,000 |
| 01-027-587 | P1081-01 | SRC1-RID [627-786] Biotinylated / Non-His Tagged (Steroid Receptor Coactivator1-receptor interaction domain) | 5,000 units (ng) | 85,000 |
| 01-027-588 | P1081-02 | SRC1-RID [627-786] Biotinylated / Non-His Tagged (Steroid Receptor Coactivator1-receptor interaction domain) | 12,500 units (ng) | 170,000 |
| 01-027-589 | P1086-01 | SRC1-RID,TEV (Steroid Receptor Coactivator1-receptor interaction domain, TEV cleavage Site) | 10,000 units (ng) | 85,000 |
| 01-027-590 | P1086-02 | SRC1-RID,TEV (Steroid Receptor Coactivator1-receptor interaction domain, TEV cleavage Site) | 25,000 units (ng) | 169,000 |
| 01-027-701 | R5025-01 | CSK (c-src Tyrosine Kinase) | 10,000 units (ng) | 93,000 |
| 01-027-702 | R5025-02 | CSK (c-src Tyrosine Kinase) | 25,000 units (ng) | 185,000 |
| 01-027-591 | P5051-01 | I-GLK (glucokinase isoform 1) | 10,000 units (ng) | 93,000 |
| 01-027-592 | P5051-02 | I-GLK (glucokinase isoform 1) | 25,000 units (ng) | 185,000 |
| 01-027-593 | P5052-01 | L-GLK (glucokinase isoform 3) | 10,000 units (ng) | 93,000 |
| 01-027-594 | P5052-02 | L-GLK (glucokinase isoform 3) | 25,000 units (ng) | 185,000 |
| 01-027-703 | R5024-01 | LCK (Lymphocyte Specific Protein Tyrosine Kinase) | 10,000 units (ng) | 93,000 |
| 01-027-704 | R5024-02 | LCK (Lymphocyte Specific Protein Tyrosine Kinase) | 25,000 units (ng) | 185,000 |
| 01-027-705 | R5048-01 | MAPK14 (Mitogen-Activated Protein Kinase 14, Baculovirus) | 5,000 units (ng) | 93,000 |
| 01-027-706 | R5048-02 | MAPK14 (Mitogen-Activated Protein Kinase 14, Baculovirus) | 12,500 units (ng) | 185,000 |
| 01-027-595 | P5049-01 | MAPK14 (Mitogen-Activated Protein Kinase 14, E coli) | 10,000 units (ng) | 93,000 |
| 01-027-596 | P5049-02 | MAPK14 (Mitogen-Activated Protein Kinase 14, E coli) | 25,000 units (ng) | 185,000 |
| 01-027-597 | P5007-01 | PIP5K2b (Phosphatidylinositol 4-phosphate 5-kinase, type II, beta) | 5,000 units (ng) | 93,000 |
| 01-027-598 | P5007-02 | PIP5K2b (Phosphatidylinositol 4-phosphate 5-kinase, type II, beta) | 12,500 units (ng) | 185,000 |
| 01-027-707 | R5008-01 | PLK1 (polo-like kinase 1) | 5,000 units (ng) | 93,000 |
| 01-027-708 | R5008-02 | PLK1 (polo-like kinase 1) | 12,500 units (ng) | 185,000 |
| 01-027-603 | P5061-01 | RPS6KB1, C-Termial Deletion (Ribosomal protein S6 kinase polypeptide 1) | 5,000 units (ng) | 93,000 |
| 01-027-604 | P5061-02 | RPS6KB1, C-Termial Deletion (Ribosomal protein S6 kinase polypeptide 1) | 12,500 units (ng) | 185,000 |
| 01-027-605 | P5053-01 | SNARK, NUAK2 (SNF1-like kinase, 2) wild Type | 5,000 units (ng) | 97,000 |
| 01-027-606 | P5053-02 | SNARK, NUAK2 (SNF1-like kinase, 2) wild Type | 12,500 units (ng) | 194,000 |
| 01-027-607 | P5054-01 | SNARK, NUAK2-MT (SNF1-like kinase, 2), Mutant K85R | 5,000 units (ng) | 97,000 |
| 01-027-608 | P5054-02 | SNARK, NUAK2-MT (SNF1-like kinase, 2), Mutant K85R | 12,500 units (ng) | 194,000 |
| 01-027-609 | R5062-01 | SYK (Spleen Tyrosine Kinase) | 5,000 units (ng) | 97,000 |
| 01-027-610 | R5062-02 | SYK (Spleen Tyrosine Kinase) | 12,500 units (ng) | 194,000 |
| 01-027-329 | P2005-01 | BRCA1 (Tumor Suppressor Protein and Transcription Factor) | 2,000 units (ng) | 112,000 |
| 01-027-330 | P2005-02 | BRCA1 (Tumor Suppressor Protein and Transcription Factor) | 5,000 units (ng) | 223,000 |
| 01-027-327 | P2011-01 | BCL-10 (B Cell Lymphoma 10) | 6,000 units (ng) | 97,000 |
| 01-027-519 | P2011-02 | BCL-10 (B Cell Lymphoma 10) | 15,000 units (ng) | 192,000 |
| 01-027-611 | P2017-01 | FGF-1 (acidic fibroblast growth factor) | 5,000 units (ng) | 85,000 |
| 01-027-612 | P2017-02 | FGF-1 (acidic fibroblast growth factor) | 12,500 units (ng) | 170,000 |
| 01-027-613 | P2018-01 | FGF-2 (basic fibroblast growth factor) | 5,000 units (ng) | 85,000 |
| 01-027-614 | P2018-02 | FGF-2 (basic fibroblast growth factor) | 12,500 units (ng) | 170,000 |
| 01-027-615 | P2013-01 | c-fos (proto oncogene) | 5,000 units(ng) | 93,000 |
| 01-027-616 | P2013-02 | c-fos (proto oncogene) | 12,500 units(ng) | 185,000 |
| 01-027-617 | P2020-01 | FRA-1 (Fos-related antigen 1) | 5,000 units (ng) | 85,000 |
| 01-027-618 | P2020-02 | FRA-1 (Fos-related antigen 1) | 12,500 units (ng) | 170,000 |
| 01-027-619 | P2025-01 | HIF-1a CTAD [776-826] (Hypoxia-Inducible Factor 1, alpha, C-terminal activation domain) | 10,000 units (ng) | 85,000 |
| 01-027-620 | P2025-02 | HIF-1a CTAD [776-826] (Hypoxia-Inducible Factor 1, alpha, C-terminal activation domain) | 25,000 units (ng) | 169,000 |
| 01-027-621 | P2026-01 | HIF-1a NTAD [530-698] (Hypoxia-Inducible Factor 1, alpha, N-terminal activation domain) | 10,000 units (ng) | 85,000 |
| 01-027-622 | P2026-02 | HIF-1a NTAD [530-698] (Hypoxia-Inducible Factor 1, alpha, N-terminal activation domain) | 25,000 units (ng) | 169,000 |
| 01-027-623 | P2014-01 | c-jun (proto oncogene) | 5,000 units(ng) | 93,000 |
| 01-027-624 | P2014-02 | c-jun (proto oncogene) | 12,500 units(ng) | 185,000 |
| 01-027-625 | P2030-01 | MAD (MAX dimerization protein 1, MXD1) | 10,000 units (ng) | 93,000 |
| 01-027-626 | P2030-02 | MAD (MAX dimerization protein 1, MXD1) | 25,000 units (ng) | 185,000 |
| 01-027-627 | P2031-01 | MAX (Myc-Associated Factor X) | 10,000 units (ng) | 93,000 |
| 01-027-628 | P2031-02 | MAX (Myc-Associated Factor X) | 25,000 units (ng) | 185,000 |
| 01-027-629 | P2021-01 | MDM2 (Mouse double minute 2) Human Oncoprotein | 10,000 units (ng) | 85,000 |
| 01-027-630 | P2021-02 | MDM2 (Mouse double minute 2) Human Oncoprotein | 25,000 units (ng) | 170,000 |
| 01-027-631 | P2015-01 | c-myc (proto oncogene) | 5,000 units(ng) | 93,000 |
| 01-027-632 | P2015-02 | c-myc (proto oncogene) | 12,500 units(ng) | 185,000 |
| 01-027-432 | P2001-01 | p53 (wild type) Tumor Suppressor Protein and Transcription Factor | 5,000 units (ng) | 98,700 |
| 01-027-433 | P2001-02 | p53 (wild type) Tumor Suppressor Protein and Transcription Factor | 12,500 units (ng) | 198,000 |
| 01-027-430 | P2002-01 | p53 [1-363] C-terminal deletion (Tumor Suppressor Protein and Transcription Factor) | 5,000 units (ng) | 98,700 |
| 01-027-431 | P2002-02 | p53 [1-363] C-terminal deletion (Tumor Suppressor Protein and Transcription Factor) | 12,500 units (ng) | 198,000 |
| 01-027-428 | P2003-01 | p53 [1-342] C-terminal deletion (Tumor Suppressor Protein and Transcription Factor) | 5,000 units (ng) | 98,700 |
| 01-027-429 | P2003-02 | p53 [1-342] C-terminal deletion (Tumor Suppressor Protein and Transcription Factor) | 12,500 units (ng) | 198,000 |
| 01-027-448 | P2007-01 | pRB (Retinoblastoma protein), Tumor Suppressor, Transcription & Proliferation Factor | 5,000 units (ng) | 112,000 |
| 01-027-449 | P2007-02 | pRB (Retinoblastoma protein), Tumor Suppressor, Transcription & Proliferation Factor | 12,500 units (ng) | 223,000 |
| 01-027-633 | P2016-01 | RAD51 | 10,000 units (ng) | 74,000 |
| 01-027-634 | P2016-02 | RAD51 | 25,000 units (ng) | 148,000 |
| 01-027-635 | P2019-01 | SV40 T-Antigen (Simian Virus 40 Large Antigen) | 5,000 units (ng) | 85,000 |
| 01-027-636 | P2019-02 | SV40 T-Antigen (Simian Virus 40 Large Antigen) | 12,500 units (ng) | 170,000 |
| 01-027-513 | P2010-01 | VHL (von Hippel-Lindau tumor suppressor protein) | 5,000 units (ng) | 97,000 |
| 01-027-514 | P2010-02 | VHL (von Hippel-Lindau tumor suppressor protein) | 12,500 units (ng) | 192,000 |
| 01-027-515 | P2008-01 | WT-1 (+KTS) Wilms' Tumor Suppressor and Transcription/Pre-mRNA Splicing Factor | 5,000 units (ng) | 112,000 |
| 01-027-516 | P2008-02 | WT-1 (+KTS) Wilms' Tumor Suppressor and Transcription/Pre-mRNA Splicing Factor | 12,500 units (ng) | 223,000 |
| 01-027-517 | P2009-01 | WT-1 (-KTS) Wilms' Tumor Suppressor and Transcription/Pre-mRNA Splicing Factor | 5,000 units (ng) | 112,000 |
| 01-027-518 | P2009-02 | WT-1 (-KTS) Wilms' Tumor Suppressor and Transcription/Pre-mRNA Splicing Factor | 12,500 units (ng) | 223,000 |
| 01-027-318 | P3001-01 | ASF/SF2, (SFRS1 or SRp30a from E Coli) Pre-mRNA Splicing Factor | 10,000 units (ng) | 78,000 |
| 01-027-319 | P3001-02 | ASF/SF2, (SFRS1 or SRp30a from E Coli) Pre-mRNA Splicing Factor | 25,000 units (ng) | 154,000 |
| 01-027-316 | P3002-01 | ASF/SF2, (SFRS1 or SRp30a from Baculovirus) Pre-mRNA Splicing Factor | 5,000 units (ng) | 112,000 |
| 01-027-317 | P3002-02 | ASF/SF2, (SFRS1 or SRp30a from Baculovirus) Pre-mRNA Splicing Factor | 12,500 units (ng) | 223,000 |
| 01-027-464 | P3003-01 | SC35, (SFRS2 or SRp30b) Pre-mRNA Splicing Factor | 5,000 units (ng) | 93,000 |
| 01-027-465 | P3003-02 | SC35, (SFRS2 or SRp30b) Pre-mRNA Splicing Factor | 12,500 units (ng) | 185,000 |
| 01-027-637 | P5101-01 | HCV-NS3/4A Protease (strain HC-J4) | 10,000 units (ng) | 93,000 |
| 01-027-638 | P5101-02 | HCV-NS3/4A Protease (strain HC-J4) | 25,000 units (ng) | 185,000 |
| 01-027-639 | P5103-01 | HCV 1a Protease (strain H77) | 10,000 units (ng) | 93,000 |
| 01-027-640 | P5103-02 | HCV 1a Protease (strain H77) | 25,000 units (ng) | 185,000 |
| 01-027-641 | P5104-01 | HCV-NS3-2a Protease (strain HC-J6) | 10,000 units (ng) | 93,000 |
| 01-027-642 | P5104-02 | HCV-NS3-2a Protease (strain HC-J6) | 25,000 units (ng) | 185,000 |
| 01-027-643 | P5105-01 | HCV-NS3-3 Protease (strain NZL1) | 10,000 units (ng) | 93,000 |
| 01-027-644 | P5105-02 | HCV-NS3-3 Protease (strain NZL1) | 25,000 units (ng) | 185,000 |
| 01-027-645 | P5102-01 | HIV Protease | 10,000 units (ng) | 93,000 |
| 01-027-646 | P5102-02 | HIV Protease | 25,000 units (ng) | 185,000 |
| 01-027-647 | P4000-01 | GST (Glutathione S-Transferase) | 10,000 units (ng) | 67,000 |
| 01-027-648 | P4000-02 | GST (Glutathione S-Transferase) | 25,000 units (ng) | 133,000 |
| 01-027-649 | P4042-01 | GST-CAR (Constitutive Androgen Receptor, GST tagged) | 10,000 units (ng) | 67,000 |
| 01-027-650 | P4042-02 | GST-CAR (Constitutive Androgen Receptor, GST tagged) | 25,000 units (ng) | 133,000 |
| 01-027-651 | P4043-01 | GST-CAR-LBD [101-348] (Constitutive Androstane Receptor, ligand binding domain, GST tagged) | 10,000 units (ng) | 67,000 |
| 01-027-652 | P4043-02 | GST-CAR-LBD [101-348] (Constitutive Androstane Receptor, ligand binding domain, GST tagged) | 25,000 units (ng) | 133,000 |
| 01-027-355 | P4016-01 | GST-CTD (RNA polymerase II, carboxy-terminal domain, GST-tagged) | 10,000 units (ng) | 70,000 |
| 01-027-356 | P4016-02 | GST-CTD (RNA polymerase II, carboxy-terminal domain, GST-tagged) | 25,000 units (ng) | 140,000 |
| 01-027-357 | P4018-01 | GST-CTF1 (GST-tagged CCAAT-Box-Binding Transcription Factor 1) | 10,000 units (ng) | 70,000 |
| 01-027-358 | P4018-02 | GST-CTF1 (GST-tagged CCAAT-Box-Binding Transcription Factor 1) | 25,000 units (ng) | 140,000 |
| 01-027-359 | P4020-01 | GST-Dr1 (NC2b 19 kDa, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-360 | P4020-02 | GST-Dr1 (NC2b 19 kDa, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-361 | P4024-01 | GST-FXR (Farnesoid-X-activated Receptor, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-362 | P4024-02 | GST-FXR (Farnesoid-X-activated Receptor, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-653 | P4044-01 | GST-EF1a (Elongation Factor 1, Alpha, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-654 | P4044-02 | GST-EF1a (Elongation Factor 1, Alpha, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-655 | P4033-01 | GST-FXR-LBD [222-472] (Farnesoid-X-activated Receptor, ligand binding domain, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-656 | P4033-02 | GST-FXR-LBD [222-472] (Farnesoid-X-activated Receptor, ligand binding domain, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-657 | P4041-01 | GST-LRH-1 (Liver Receptor Homolog 1, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-658 | P4041-02 | GST-LRH-1 (Liver Receptor Homolog 1, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-363 | P4025-01 | GST-LXR-a (Liver-X Receptor, alpha isoform, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-364 | P4025-02 | GST-LXR-a (Liver-X Receptor, alpha isoform, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-367 | P4026-01 | GST-LXR-b (Liver-X Receptor, beta isoform, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-368 | P4026-02 | GST-LXR-b (Liver-X Receptor, beta isoform, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-659 | P4034-01 | GST-LXRb-LBD [211-461] (Liver-X Receptor, beta isoform, ligand binding domain, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-660 | P4034-02 | GST-LXRb-LBD [211-461] (Liver-X Receptor, beta isoform, ligand binding domain, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-365 | P4027-01 | GST-LXRƒ¿-LBD (Liver-X Receptor, alpha, ligand binding domain, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-366 | P4027-02 | GST-LXRƒ¿-LBD (Liver-X Receptor, alpha, ligand binding domain, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-661 | P4029-01 | GST-LXRƒ¿-N182 (Liver-X Receptor, alpha isoform, N term 1-182 region, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-662 | P4029-02 | GST-LXRƒ¿-N182 (Liver-X Receptor, alpha isoform, N term 1-182 region, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-371 | P4002-01 | GST-p53 (wild type) Tumor Suppressor Protein and Transcription Factor (GST-tagged 1-81) | 10,000 units (ng) | 60,000 |
| 01-027-372 | P4002-02 | GST-p53 (wild type) Tumor Suppressor Protein and Transcription Factor (GST-tagged 1-81) | 25,000 units (ng) | 119,000 |
| 01-027-369 | P4003-01 | GST-p53 (mt) Tumor Suppressor Protein and Transcription Factor (GST-tagged 1-81) | 10,000 units (ng) | 60,000 |
| 01-027-370 | P4003-02 | GST-p53 (mt) Tumor Suppressor Protein and Transcription Factor (GST-tagged 1-81) | 25,000 units (ng) | 119,000 |
| 01-027-663 | P4030-01 | GST-PPARƒ¿ (Peroxisome proliferator-activated receptor, alpha isotype, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-664 | P4030-02 | GST-PPARƒ¿ (Peroxisome proliferator-activated receptor, alpha isotype, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-524 | P4031-01 | GST-PPARƒ¿-LBD (Peroxisome proliferator-activated receptor, alpha isotype, lidgand binding dom, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-525 | P4031-02 | GST-PPARƒ¿-LBD (Peroxisome proliferator-activated receptor, alpha isotype, lidgand binding dom, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-665 | P4035-01 | GST-PPARd-LBD (Peroxisome proliferator-activated receptor, delta isotype, lidgand binding dom, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-666 | P4035-02 | GST-PPARd-LBD (Peroxisome proliferator-activated receptor, delta isotype, lidgand binding dom, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-667 | P4036-01 | GST-PPARg-LBD [204-477] (Peroxisome proliferator-activated receptor, gamma, lidgand binding, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-668 | P4036-02 | GST-PPARg-LBD [204-477] (Peroxisome proliferator-activated receptor, gamma, lidgand binding, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-373 | P4010-01 | GST-RAP30 (Transcription Factor IIF, GST-tagged Rap30 subunit) | 10,000 units (ng) | 70,000 |
| 01-027-374 | P4010-02 | GST-RAP30 (Transcription Factor IIF, GST-tagged Rap30 subunit) | 25,000 units (ng) | 140,000 |
| 01-027-669 | P4037-01 | GST-RARa-LBD [154-462] (Retinoic Acid Receptor, alpha, ligand binding domain, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-670 | P4037-02 | GST-RARa-LBD [154-462] (Retinoic Acid Receptor, alpha, ligand binding domain, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-671 | P4038-01 | GST-RARb-LBD [173-409] (Retinoic Acid Receptor, beta, ligand binding domain, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-672 | P4038-02 | GST-RARb-LBD [173-409] (Retinoic Acid Receptor, beta, ligand binding domain, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-673 | P4028-01 | GST-RAR-ƒÁ (Retinoic Acid Receptor, gamma isoform, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-674 | P4028-02 | GST-RAR-ƒÁ (Retinoic Acid Receptor, gamma isoform, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-675 | P4039-01 | GST-RARg-LBD [150-417] (Retinoic Acid Receptor, gamma, ligand binding domain, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-676 | P4039-02 | GST-RARg-LBD [150-417] (Retinoic Acid Receptor, gamma, ligand binding domain, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-381 | P4011-01 | GST-RPB5 (RNA polymerase II, GST-tagged p33 subunit) | 10,000 units (ng) | 70,000 |
| 01-027-382 | P4011-02 | GST-RPB5 (RNA polymerase II, GST-tagged p33 subunit) | 25,000 units (ng) | 140,000 |
| 01-027-383 | P4012-01 | GST-RPB6 (RNA polymerase II, GST-tagged p15.6 subunit) | 10,000 units (ng) | 70,000 |
| 01-027-384 | P4012-02 | GST-RPB6 (RNA polymerase II, GST-tagged p15.6 subunit) | 25,000 units (ng) | 140,000 |
| 01-027-397 | P4005-01 | GST-RPB8 (RNA Polymerase II, GST-tagged RPB8 Subunit) | 10,000 units (ng) | 70,000 |
| 01-027-398 | P4005-02 | GST-RPB8 (RNA Polymerase II, GST-tagged RPB8 Subunit) | 25,000 units (ng) | 140,000 |
| 01-027-385 | P4013-01 | GST-RPB9 (RNA polymerase II, GST-tagged p14.5 subunit) | 10,000 units (ng) | 70,000 |
| 01-027-386 | P4013-02 | GST-RPB9 (RNA polymerase II, GST-tagged p14.5 subunit) | 25,000 units (ng) | 140,000 |
| 01-027-377 | P4014-01 | GST-RPB10 (RNA polymerase II, GST-tagged RPB10 subunit) | 10,000 units (ng) | 70,000 |
| 01-027-378 | P4014-02 | GST-RPB10 (RNA polymerase II, GST-tagged RPB10 subunit) | 25,000 units (ng) | 140,000 |
| 01-027-379 | P4015-01 | GST-RPB12 (RNA polymerase II, GST-tagged RPB12 subunit) | 10,000 units (ng) | 70,000 |
| 01-027-380 | P4015-02 | GST-RPB12 (RNA polymerase II, GST-tagged RPB12 subunit) | 25,000 units (ng) | 140,000 |
| 01-027-389 | P4021-01 | GST-RXRƒ¿-LBD (Retinoid X Receptor-alpha, 200-462, Ligand binding domain, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-390 | P4021-02 | GST-RXRƒ¿-LBD (Retinoid X Receptor-alpha, 200-462, Ligand binding domain, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-391 | P4019-01 | GST-Sp1 (GC-box Binding Protein, GST-tagged) | 10,000 units (ng) | 70,000 |
| 01-027-392 | P4019-02 | GST-Sp1 (GC-box Binding Protein, GST-tagged) | 25,000 units (ng) | 140,000 |
| 01-027-677 | P4040-01 | GST-SRC1-RID [627-786] (Steroid Receptor coactivator1-receptor interaction domain, GST tagged) | 10,000 units (ng) | 67,000 |
| 01-027-678 | P4040-02 | GST-SRC1-RID [627-786] (Steroid Receptor coactivator1-receptor interaction domain, GST tagged) | 25,000 units (ng) | 133,000 |
| 01-027-393 | P4001-01 | GST-TBP (GST-tagged TATA box Binding Protein) | 10,000 units (ng) | 70,000 |
| 01-027-394 | P4001-02 | GST-TBP (GST-tagged TATA box Binding Protein) | 25,000 units (ng) | 140,000 |
| 01-027-399 | P4004-01 | GST-TFIIA [p55] (Transription Factor IIA, GST-tagged p55 subunit) | 10,000 units (ng) | 70,000 |
| 01-027-401 | P4004-02 | GST-TFIIA [p55] (Transription Factor IIA, GST-tagged p55 subunit) | 25,000 units (ng) | 140,000 |
| 01-027-395 | P4006-01 | GST-TFIIA [p12] (Transcription Factor IIA, GST-tagged g subunit) | 10,000 units (ng) | 70,000 |
| 01-027-396 | P4006-02 | GST-TFIIA [p12] (Transcription Factor IIA, GST-tagged g subunit) | 25,000 units (ng) | 140,000 |
| 01-027-402 | P4007-01 | GST-TFIIB (Transcription Factor IIB, GST-tagged) | 10,000 units (ng) | 70,000 |
| 01-027-403 | P4007-02 | GST-TFIIB (Transcription Factor IIB, GST-tagged) | 25,000 units (ng) | 140,000 |
| 01-027-404 | P4008-01 | GST-TFIIEa, [p56] (Transcription Factor IIE, GST-tagged a subunit) | 10,000 units (ng) | 70,000 |
| 01-027-405 | P4008-02 | GST-TFIIEa, [p56] (Transcription Factor IIE, GST-tagged a subunit) | 25,000 units (ng) | 140,000 |
| 01-027-406 | P4023-01 | GST-TR-a1 (Thyroid Hormone Receptor, a1 isoform. GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-407 | P4023-02 | GST-TR-a1 (Thyroid Hormone Receptor, a1 isoform. GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-679 | P4032-01 | GST-USF1, (Human Upstream Stimulatory Factor 1, GST-tagged) | 10,000 units (ng) | 67,000 |
| 01-027-680 | P4032-02 | GST-USF1, (Human Upstream Stimulatory Factor 1, GST-tagged) | 25,000 units (ng) | 133,000 |
| 01-027-408 | P4017-01 | GST-VP16 [GST-tagged VP16(411-490)] | 10,000 units (ng) | 70,000 |
| 01-027-409 | P4017-02 | GST-VP16 [GST-tagged VP16(411-490)] | 25,000 units (ng) | 140,000 |
| 01-027-681 | PA100-01 | a -GST (anti-Glutathione S-Transferase) | 100ug | 103,000 |
| 01-027-320 | PA101-01 | a -TBP (anti-hTBP) | 100ug | 103,000 |
| 01-027-321 | PA102-01 | a -TFIIA (anti-p55) | 100ug | 103,000 |
| 01-027-322 | PA103-01 | a -TFIIEa (anti-p56) | 100ug | 103,000 |
| 01-027-323 | PA104-01 | a -TFIIEb (anti-p34) | 100ug | 103,000 |
| 01-027-325 | PA105-01 | a -TFIIF (anti-RAP74) | 100ug | 103,000 |
| 01-027-324 | PA106-01 | a -TFIIF (anti-RAP30) | 100ug | 103,000 |
| 01-027-682 | PA107-01 | a -TFIIH (anti-p62) | ¦ | 103,000 |
| 01-027-311 | PA108-01 | a -RNA Pol II (anti-CTD) | 100ug | 103,000 |
| 01-027-313 | PA109-01 | a -RNA Pol II (anti-p33) | 100ug | 103,000 |
| 01-027-312 | PA110-01 | a -RNA Pol II (anti-p14.5) | 100ug | 103,000 |
| 01-027-308 | PA111-01 | a -DR1 | 100ug | 103,000 |
| 01-027-309 | PA112-01 | a -HMG-1 | 100ug | 103,000 |
| 01-027-307 | PA113-01 | a -DNA Topoisomerase I | 100ug | 103,000 |
| 01-027-314 | PA114-01 | a -RXR (anti-RXR-LBD) | 100ug | 103,000 |
| 01-027-310 | PA115-01 | a -p53 | 100ug | 103,000 |
| 01-027-326 | PA116-01 | a -VHL | 100ug | 103,000 |
| 01-027-683 | PA117-01 | a -PC4 | 100ug | 103,000 |
| 01-027-684 | PA118-01 | a -p52 | 100ug | 103,000 |
| 01-027-685 | PA119-01 | a -p75 (a-LEDGF) | 100ug | 103,000 |
| 01-027-686 | PA120-01 | a -Sp1 | 100ug | 103,000 |
| 01-027-687 | PA121-01 | a -IGLK (Islet Glucokinase) | 100ug | 103,000 |
| 01-027-688 | PA122-01 | a -IGLK (Glucokinase Isoform 3) | 100ug | 103,000 |
| 01-027-315 | PA301-01 | a -SC35 | 100ug | 103,000 |
| 01-027-301 | P7000-01 | RNA POL II Basal In Vitro Transcription Kit (G-Less Cassette) | 10 reactions | 117,000 |
| 01-027-302 | P7000-02 | RNA POL II Basal In Vitro Transcription Kit (G-Less Cassette) | 20 reactions | 217,000 |
| 01-027-536 | P6000-01 | GR EMSA Kit | 20 Reactions | 162,000 |
| 01-027-537 | P6001-01 | PPARa EMSA Kit (Complete Heterodimer Format) | 20 Reactions | 214,000 |
| 01-027-538 | P6002-01 | PPARb EMSA Kit (Complete Heterodimer Format) | 20 Reactions | 214,000 |
| 01-027-539 | P6003-01 | PPARg EMSA Kit (Complete Heterodimer Format) | 20 Reactions | 214,000 |
| 01-027-540 | P6004-01 | PPAR Triad EMSA Kit (PPARa,b, & g) 10 Reactions Each (Complete Heterodimer Format) | 10 Reactions | 305,000 |
| 01-027-520 | P8001-01 | Active Protein Array, Transcription Array Nitrocellulose Membrane(36 Targets) | 2 Arrays | 171,000 |
| 01-027-530 | P8001-02 | Active Protein Array, Transcription Array Nitrocellulose Membrane(36 Targets) | 4 Arrays | 298,000 |
| 01-027-523 | P8001-03 | Active Protein Array, Transcription Array Nitrocellulose Glass Slide(36 Targets) | 2 Arrays | 182,000 |
| 01-027-531 | P8001-04 | Active Protein Array, Transcription Array Nitrocellulose Glass Slide(36 Targets) | 4 Arrays | 309,000 |